Vonoprazan shows efficacy similar to that of proton pump inhibitors with respect to symptomatic, endoscopic, and histological responses in patients with eosinophilic esophagitis.
Takuya KuzumotoFumio TanakaAkinari SawadaYuji NadataniKoji OtaniShuhei HosomiNoriko KamataKoichi TairaYasuaki NagamiTetsuya TanigawaToshio WatanabeYasuhiro FujiwaraPublished in: Esophagus : official journal of the Japan Esophageal Society (2020)
Vonoprazan showed similar efficacy to PPIs in EoE.